Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.110
+0.010 (0.91%)
At close: May 16, 2025, 4:00 PM
1.150
+0.040 (3.60%)
After-hours: May 16, 2025, 4:38 PM EDT
Ikena Oncology Market Cap
Ikena Oncology has a market cap or net worth of $53.57 million as of May 16, 2025. Its market cap has decreased by -14.62% in one year.
Market Cap
53.57M
Enterprise Value
-53.87M
1-Year Change
-14.62%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on March 26, 2021, Ikena Oncology's market cap has decreased from $553.41M to $53.57M, a decrease of -90.32%. That is a compound annual growth rate of -43.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 53.57M | -32.32% |
| Dec 31, 2024 | 79.14M | -16.75% |
| Dec 29, 2023 | 95.07M | -1.43% |
| Dec 30, 2022 | 96.44M | -78.58% |
| Dec 31, 2021 | 450.27M | -18.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |